ArticleJournal for immunotherapy of cancer2022
Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh
Jieling Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.